Key Takeaways
- MSFT shares advanced 1.4% to $401.10 on Thursday, reaching an intraday peak of $405.99.
- Morgan Stanley’s Josh Baer reaffirmed his Buy recommendation with a $650 target, highlighting Microsoft’s commanding AI position.
- CIO survey reveals 62% intend to boost Azure expenditures in the coming year, versus 57% in the previous period.
- Legal challenges emerge with class-action filings claiming misleading statements about AI and Copilot uptake.
- The company reports quarterly results on July 29, with focus on Copilot traction and AI revenue generation.
Microsoft (MSFT) shares posted a 1.4% gain on Thursday, closing at $401.10 after touching $405.99 during the session. The advance followed Wednesday’s close of $395.63, with trading volume marginally below the typical 37.5 million share average.
The rally arrives as the tech giant prepares to unveil fiscal Q4 results on July 29, drawing increased investor scrutiny.
Morgan Stanley analyst Josh Baer reinforced his Buy stance on the stock prior to the upcoming report, maintaining his $650 valuation. His optimism stems from fresh CIO survey findings suggesting Microsoft’s artificial intelligence traction exceeds market expectations. Trading at approximately 16 times projected fiscal 2028 earnings, Baer considers the valuation attractive relative to Azure’s expansion potential.
The survey results present compelling evidence. Roughly 62% of chief information officers intend to expand Azure investments over the next twelve months, climbing from 57% previously. Microsoft 365 is experiencing similar momentum — 65% of CIOs anticipate higher spending, up from 55% last year and significantly above the 46% recorded two years earlier.
Additionally, enterprise customers are gravitating toward premium offerings. Half of surveyed CIOs project utilizing the E5 suite next year, while 21% plan transitioning to the more expensive E7 tier. This upward migration signals positive implications for per-seat revenue metrics.
Collectively, CIOs forecast Microsoft expenditure growth of 7.6% over the next twelve months — the strongest projection among all surveyed vendors.
Cloud Platform and AI Assistant Drive Narrative
Microsoft recently revealed a collaboration with 3M focused on advancing AI-powered data center infrastructure and enterprise digital transformation, providing another validation point for the Azure ecosystem.
Copilot penetration will be critical on July 29. Market watchers are eager to understand how CIO interest is translating into tangible revenue streams. The previous quarterly disclosure offered encouraging signals — Microsoft delivered $4.27 in earnings per share for the period ending April 29, surpassing the $4.06 consensus, while revenue reached $82.89 billion, representing 18.3% annual growth.
The average Street price target stands at $559.63, suggesting approximately 38% appreciation potential from present levels. Among 42 tracked analysts, 41 maintain Buy recommendations and seven rate the stock at Hold. The overall consensus registers as “Moderate Buy.”
Challenges on the Horizon
Obstacles persist despite positive momentum. Several Wall Street institutions have lowered their valuations ahead of earnings, expressing concerns about escalating AI infrastructure investments and potential margin compression.
Litigation risks are mounting. Several class-action complaints have been initiated alleging the company provided misleading information regarding Copilot and AI adoption metrics, with the lead plaintiff deadline set for August 11, 2026.
The Xbox gaming division continues weighing on investor sentiment. Following an $80 billion gaming investment, the business unit is experiencing significant restructuring, including workforce reductions and strategic realignment.
Recent insider transactions include CEO Judson Althoff divesting 15,500 shares on June 1 at $460.99 each, totaling approximately $7.1 million. EVP Takeshi Numoto sold 4,500 shares at $402.84 on June 10.
Citigroup elevated MSFT from “market outperform” to “overweight” on Thursday. Wells Fargo preserved its “overweight” designation while reducing its price objective from $650 to $625.



